223 related articles for article (PubMed ID: 29978254)
1. The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.
Gilsenan A; Harding A; Kellier-Steele N; Harris D; Midkiff K; Andrews E
Osteoporos Int; 2018 Oct; 29(10):2335-2343. PubMed ID: 29978254
[TBL] [Abstract][Full Text] [Related]
2. Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study.
Gilsenan A; Harris D; Reynolds M; McSorley D; Midkiff K; Jackson L; Muldavin B; Kellier-Steele N; Andrews E
Osteoporos Int; 2021 Apr; 32(4):645-651. PubMed ID: 33151378
[TBL] [Abstract][Full Text] [Related]
3. Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data.
Gilsenan A; Midkiff K; Harris D; McQuay L; Hunter S; Kellier-Steele N; Andrews E
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1616-1626. PubMed ID: 32894794
[TBL] [Abstract][Full Text] [Related]
4. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.
Andrews EB; Gilsenan AW; Midkiff K; Sherrill B; Wu Y; Mann BH; Masica D
J Bone Miner Res; 2012 Dec; 27(12):2429-37. PubMed ID: 22991313
[TBL] [Abstract][Full Text] [Related]
5. Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study.
Gilsenan A; Midkiff K; Harris D; Kellier-Steele N; McSorley D; Andrews EB
J Bone Miner Res; 2021 Feb; 36(2):244-251. PubMed ID: 32990990
[TBL] [Abstract][Full Text] [Related]
6. Assessing the incidence of osteosarcoma among teriparatide-treated patients using linkage of commercial pharmacy and state cancer registry data, contributing to the removal of boxed warning and other labeling changes.
Kellier-Steele N; Casso D; Anderson A; Oliveria SA; Motsko S
Bone; 2022 Jul; 160():116394. PubMed ID: 35318162
[TBL] [Abstract][Full Text] [Related]
7. Of mice and men: divergent risks of teriparatide-induced osteosarcoma.
Subbiah V; Madsen VS; Raymond AK; Benjamin RS; Ludwig JA
Osteoporos Int; 2010 Jun; 21(6):1041-5. PubMed ID: 19597911
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of a Large Prospective Cohort in the United States Using Linkage With Multiple State Cancer Registries.
Jacobs EJ; Briggs PJ; Deka A; Newton CC; Ward KC; Kohler BA; Gapstur SM; Patel AV
Am J Epidemiol; 2017 Oct; 186(7):876-884. PubMed ID: 28520845
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
Duong LM; Richardson LC
J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
[TBL] [Abstract][Full Text] [Related]
10. [Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].
Kajüter H; Geier AS; Wellmann I; Krieg V; Fricke R; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):52-9. PubMed ID: 24357173
[TBL] [Abstract][Full Text] [Related]
11. Probable osteosarcoma risk after prolonged teriparatide treatment: comment on the article by Saag et al.
Tastekin N; Zateri C
Arthritis Rheum; 2010 Jun; 62(6):1837; author reply 1837-8. PubMed ID: 20191586
[No Abstract] [Full Text] [Related]
12. Initial experience with teriparatide in the United States.
Gold DT; Pantos BS; Masica DN; Misurski DA; Marcus R
Curr Med Res Opin; 2006 Apr; 22(4):703-8. PubMed ID: 16684431
[TBL] [Abstract][Full Text] [Related]
13. Regional variation and challenges in estimating the incidence of giant cell tumor of bone.
Liede A; Bach BA; Stryker S; Hernandez RK; Sobocki P; Bennett B; Wong SS
J Bone Joint Surg Am; 2014 Dec; 96(23):1999-2007. PubMed ID: 25471915
[TBL] [Abstract][Full Text] [Related]
14. The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication.
Midkiff KD; Andrews EB; Gilsenan AW; Deapen DM; Harris DH; Schymura MJ; Hornicek FJ
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):960-8. PubMed ID: 27091234
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
[TBL] [Abstract][Full Text] [Related]
16. Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jan; 22(1):133-143. PubMed ID: 27847134
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
[TBL] [Abstract][Full Text] [Related]
18. Linkage of Indiana State Cancer Registry and Indiana Network for Patient Care Data.
Ruppert LP; He J; Martin J; Eckert G; Ouyang F; Church A; Dexter P; Hui S; Haggstrom D
J Registry Manag; 2016; 43(4):174-8. PubMed ID: 29595920
[TBL] [Abstract][Full Text] [Related]
19. [The importance of the common cancer registry for the identification of cancer cases in the EPIC Potsdam-study -- results of the first record linkage].
Bergmann MM; Noethlings U; Eisinger B; Streller B; Quehl A; Walter D; Lahmann PH; Boeing H
Gesundheitswesen; 2004; 66(8-9):475-81. PubMed ID: 15372347
[TBL] [Abstract][Full Text] [Related]
20. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
